Search results for "Option"

showing 10 items of 345 documents

L'impact de l'adoption des normes IAS/IFRS sur les capitaux propres des banques européennes ?

2009

"L'impact de l'adoption des normes IAS/IFRS sur les capitaux propres des banques européennes ? "L'impact de l'adoption des normes IAS/IFRS sur les capitaux propres des banques européennes ?[SHS.GESTION]Humanities and Social Sciences/Business administration[SHS.GESTION] Humanities and Social Sciences/Business administration[ SHS.GESTION ] Humanities and Social Sciences/Business administrationnormes IAS/IFRS sur les capitaux propres des banques européennes ? impact
researchProduct

Can green infrastructure help to conserve biodiversity?

2017

The gradually decreasing connectivity of habitats threatens biodiversity and ecological processes valuable to humans. Green infrastructure is promoted by the European Commission as a key instrument for the conservation of ecosystems in the EU biodiversity strategy to 2020. Green infrastructure has been defined as a network of natural and semi-natural areas, designed and managed to deliver a wide range of ecosystem services. We surveyed Finnish experts' perceptions on the development of green infrastructure within the existing policy framework. Our results show that improving the implementation of existing conservation policy instruments needs to be an integral part of developing green infr…

0106 biological sciencesPublic AdministrationADOPTIONGeography Planning and Developmentta11720211 other engineering and technologiesBiodiversity02 engineering and technologyManagement Monitoring Policy and LawEnvironmental Science (miscellaneous)010603 evolutionary biology01 natural sciences12. Responsible consumptionEcosystem servicesGreen economyCONNECTIVITYenvironmental policy11. Sustainabilitymedia_common.cataloged_instanceEuropean commissionKNOWLEDGEbiodiversity governanceta519European UnionEuropean union1172 Environmental sciencesmedia_commonbusiness.industryEnvironmental resource management021107 urban & regional planningenvironmental governance15. Life on landEnvironmental governanceHabitat13. Climate actionta1181FRAGMENTATIONbusinessGreen infrastructureecosystem servicesEnvironment and Planning C: Government and Policy
researchProduct

The adoption of green energy technologies: The role of policies in Austria, Germany, and Switzerland

2017

We contribute to the existing research about policy-induced technology adoption in several ways. First, we suggest a new survey design to measure the energy-related policy environment. Second, we simultaneously estimate the policy effects for the adoption propensity and the adoption intensity simultaneously and, third, we compare the policy effects in the three countries, Austria, Germany, and Switzerland. Based on a representative sample of firms for all three countries we find that policies essentially promote the adoption of technologies and they are practically ineffective for the intensity, which poses a great challenge to future policy designs. Voluntary agreements or demand-related f…

020209 energy02 engineering and technology7. Clean energyEnergy policyArticlecountry comparison0502 economics and business0202 electrical engineering electronic engineering information engineeringenergy technologyenergy innovations050207 economicsta512energiaPublic economicsRenewable Energy Sustainability and the Environmentbusiness.industryfirm-level adoption05 social sciencesEnvironmental resource managementSurvey researchSubsidyOriginal ArticlesRenewable energyinnovaatiotenergiapolitiikka13. Climate actionenergiateknologiaEnergy policy; Energy technology; Firm-level adoption; Energy innovations; Country comparisonbusinessEnergy policyInternational Journal of Green Energy
researchProduct

Pricing Sovereign Contingent Convertible Debt

2016

We develop a pricing model for sovereign contingent convertible bonds (S-CoCo) with payment standstills triggered by a sovereign's credit default swap CDS spread. One innovation is the modeling of CDS spread regime switching which is prevalent during crises. Regime switching is modeled as a hidden Markov process and is integrated with a stochastic process of spread levels to obtain S-CoCo prices through simulation. The paper goes a step further and uses the pricing model in a Longstaff-Schwartz. American option pricing framework to compute state contingent S-CoCo prices at some risk horizon, thus facilitating risk management. Dual trigger pricing is also discussed using the idiosyncratic CD…

021103 operations researchCredit default swapbusiness.industryFinancial economicsmedia_common.quotation_subject05 social sciences0211 other engineering and technologies02 engineering and technologyPaymentStock market indexDebt restructuringValuation of options0502 economics and businessEconomics050207 economicsRational pricingbusinessConvertible bondRisk managementmedia_commonSSRN Electronic Journal
researchProduct

Phase 1b/3 study of avelumab-based combination regimens in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).

2017

TPS7575 Background: Approximately 50% of patients (pts) with advanced DLBCL are refractory to or relapse following first line R-CHOP therapy. Pts with R/R DLBCL have limited treatment options and a poor prognosis. This study assesses immunotherapy-based regimens containing avelumab (a fully human IgG1 anti–PD-L1 antibody) in combination with utomilumab (a novel 4-1BB agonist), azacitidine, rituximab, and/or conventional chemotherapy (CT; bendamustine) in pts with R/R DLBCL. Methods: JAVELIN DLBCL (NCT02951156) is a global, multicenter, randomized, open-label, 2-component(phase 1b followed by phase 3) study of avelumab-based combination regimens in R/R DLBCL. In phase 1b, up to 84 pts will …

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtybusiness.industryFirst lineTreatment optionsAvelumab03 medical and health sciences030104 developmental biologyOncologyRefractoryhemic and lymphatic diseasesInternal medicinemedicineRefractory Diffuse Large B-Cell LymphomaIn patientbusinessmedicine.drugJournal of Clinical Oncology
researchProduct

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma

2017

Despite markedly improved treatment options for metastatic melanoma, resistance to targeted therapies such as BRAF inhibitors (BRAFi) or BRAFi plus MEK inhibitors (MEKi) remains a major problem. Our aim was to characterize progression on BRAFi therapy and outcome of subsequent treatment. One hundred and eighty patients with BRAF-mutant metastatic melanoma who had progressed on treatment with single-agent BRAFi from February 2010 to April 2015 were included in a retrospective data analysis focused on patterns of progression, treatment beyond progression (TBP) and subsequent treatments after BRAFi therapy. Analysis revealed that 51.1% of patients progressed with both new and existing metastas…

0301 basic medicineOncologyMaleCancer ResearchSkin NeoplasmsBRAF inhibitorProgrammed Cell Death 1 ReceptorMedizinKaplan-Meier Estimate0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsVemurafenibMelanomaOriginal ResearchAged 80 and overTreatment optionsMiddle AgedMAP Kinase Kinase KinasesPrognosisProgression-Free SurvivalOncology030220 oncology & carcinogenesisDisease ProgressionvemurafenibFemalemedicine.drugmetastatic melanomaBRAF inhibitorAdultProto-Oncogene Proteins B-rafmedicine.medical_specialtyMetastatic melanomaRetrospective data03 medical and health sciencesYoung AdultInternal medicinetreatment beyond progressionmedicineOverall survivalHumansRadiology Nuclear Medicine and imagingIn patientdabrafenibProtein Kinase InhibitorsResponse Evaluation Criteria in Solid TumorsAgedRetrospective Studiesbusiness.industryClinical Cancer ResearchDabrafenib030104 developmental biologyBRAF mutationDrug Resistance NeoplasmMutationprogressionbusinessFollow-Up StudiesCancer Medicine
researchProduct

International consensus guidelines for scoring the histopathological growth patterns of liver metastasis

2017

BACKGROUND: Liver metastases present with distinct histopathological growth patterns (HGPs), including the desmoplastic, pushing and replacement HGPs and two rarer HGPs. The HGPs are defined owing to the distinct interface between the cancer cells and the adjacent normal liver parenchyma that is present in each pattern and can be scored from standard haematoxylin-and-eosin-stained (H&E) tissue sections. The current study provides consensus guidelines for scoring these HGPs.METHODS: Guidelines for defining the HGPs were established by a large international team. To assess the validity of these guidelines, 12 independent observers scored a set of 159 liver metastases and interobserver var…

0301 basic medicineOncologycongenital hereditary and neonatal diseases and abnormalitiesCancer Researchmedicine.medical_specialtyPathologyIntraclass correlationmedicine.medical_treatmentcolorectal cancerGuidelineMetastasisangiogenesis03 medical and health sciencesbreast cancer0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicineJournal ArticlemedicineHumansNeoplasm Metastasisprognostic factorintegumentary systembusiness.industryLiver Neoplasmsnutritional and metabolic diseasesvessel co-optionGold standard (test)medicine.diseaseliver metastasis030104 developmental biologyTissue sectionsPractice GuidelineOncology030220 oncology & carcinogenesisCancer cellCohortBiomarker (medicine)Hepatectomytumour microenvironmentbusinessBritish Journal of Cancer
researchProduct

Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience.

2019

Hepatopulmonary syndrome (HPS) is a pulmonary vascular complication of liver disease that affects up to 30% of patients with cirrhosis [1]. Intrapulmonary vascular dilatations and shunts result in gas exchange abnormalities, ranging from elevated alveolar-arterial oxygen gradients with no hypoxemia to very severe hypoxemia [1, 2]. Currently, liver transplantation (LT) is the only treatment option [3]. The Model for End-Stage Liver Disease (MELD) is a scoring system for assessing liver disease severity that has been validated to predict the 3-months waitlist mortality, and is used by Eurotransplant for prioritising allocation of liver transplants [4]. Footnotes This manuscript has recently b…

0301 basic medicinePulmonary and Respiratory MedicineRiskScoring systemmedicine.medical_treatmentMedizinVascular complicationLiver transplantationEnd Stage Liver Disease03 medical and health sciences0302 clinical medicineSevere hypoxemiaNothingMedicineHumansRegistriesProportional Hazards ModelsRetrospective Studiesbusiness.industryConflict of interestTreatment optionsLiver TransplantationEuropeOxygen030104 developmental biologyTreatment OutcomeLaw030211 gastroenterology & hepatologybusinessProduction teamHepatopulmonary SyndromeThe European respiratory journal
researchProduct

Purchase intention and purchase behavior online: A cross-cultural approach

2020

This article aims to explore the key factors on e-commerce adoption from elements of social psychology, such as attitude, subjective norms, perceived behavioral control, ease of use and perceived usefulness, introducing the study of non-traditional elements like buying impulse, compatibility, and self-efficacy in online stores, contrasting relationships in a cross-cultural environment. The proposed model is tested from quantitative research with a sample of 584 online consumers in Colombia and Spain. The following statistical analyses were conducted: CFA, structural equations, measurement instrument invariance, and multi-group analysis with EQS 6.3 software. The study reveals that self-effi…

0301 basic medicineTechnology managementOnline purchase intentionColombiaDecision analysisArticlePurchase behavior03 medical and health sciencesCross-cultural psychology0302 clinical medicineStatistical analysesBusinessCross-cultural studylcsh:Social sciences (General)Marketinglcsh:Science (General)Practical implicationsMarketingMultidisciplinarybusiness.industryNational cultureUsabilityConsumer attitudeTechnology management030104 developmental biologyKey factorsSpainlcsh:H1-99businessPsychology030217 neurology & neurosurgerylcsh:Q1-390Technology adoptionDecision analysisHeliyon
researchProduct

A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era. Selecting cases, matching clinical bene…

2019

An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is crucial for the choice of proper treatment. Presently, precise recognition of these disorders relies on the combination of morphological, immunophenotypical, and cytogenetic/molecular features. The diagnostic workup in such situations implies the application of costly and time-consuming analyses, which are not always required, since an intensified treatment option is reasonably reserved to fit patients. The Italian Group of Haematopathology proposes herein a practical algorithm for the diagnosis of aggressive mature B cell lymphomas based on a stepwise approach, aimed to select cases deserving mo…

0301 basic medicinemedicine.medical_specialtyMatching (statistics)Lymphoma B-CellLymphomadouble hitComputer scienceMYCDouble hitFluorescencePathology and Forensic MedicineImmunophenotyping03 medical and health sciences0302 clinical medicineFISHDiagnosismedicinePractical algorithmHumansIntensive care medicineB-cell lymphomaMolecular BiologyIn Situ HybridizationIn Situ Hybridization FluorescenceHGBLBrief ReportB-CellTreatment optionsCorrectionDiagnosis; DLBCL; Double hit; FISH; HGBL; MYC; Humans; Immunophenotyping; In Situ Hybridization Fluorescence; Lymphoma B-Cell; AlgorithmsCell BiologyGeneral MedicineDiagnosis DLBCL Double hit FISH HGBL MYCmedicine.diseaseDiagnosis; DLBCL; double hit; FISH; HGBL; MYCOptimal managementMolecular analysis030104 developmental biology030220 oncology & carcinogenesisDLBCLPosition paperProper treatmentAlgorithmsDiagnosiHuman
researchProduct